Back

HMOX1 controls a heme/ferritin switch that protects cells from ferroptosis

de Souza, I.; Andrade, I. A. M.; Freitas, F. P.; Teixeira, A. B. d. S.; Ramalho, M. C. C.; Lima, K. A.; dos Santos, A. F.; Fazeli, G.; Schmitz, W.; Rocha, C. R. R.; Angeli, J. P. F.

2025-10-15 cancer biology
10.1101/2025.10.14.682408 bioRxiv
Show abstract

Modulating the intracellular labile iron pool (LIP) has emerged as a promising strategy to induce ferroptosis in cancer cells, offering a way to overcome resistance to apoptosis-based therapies. One of the main contributors to LIP is heme catabolism mediated by heme oxygenase-1 (HMOX1), which promotes ferroptosis sensitivity by releasing free iron. Beyond its role as an iron donor, heme can influence diverse proteins and signaling pathways that drive tumor progression, but how heme regulates ferroptosis remains poorly understood. Here, we uncover a paradoxical, protective function of heme in the absence of HMOX1 activity. When HMOX1 is inactive, heme becomes stabilized, leading to ferritin upregulation, suppression of ferroptosis, and rescue of cell death induced by both pharmacological and genetic inhibition of GPX4. Our findings reveal an unrecognized heme-HMOX1-ferritin axis that controls ferroptosis sensitivity. Targeting this pathway may offer a new therapeutic strategy to modulate ferroptosis in cancer.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 6%
22.7%
Similar papers in this journal
2
Nature Cell Biology
○ 118 papers in training set
Top 0.2%
8.0%
Similar papers in this journal
3
Cell Death & Differentiation
○ 48 papers in training set
Top 0.1%
5.6%
Similar papers in this journal
4
eLife
● 5828 papers in training set
Top 27%
4.4%
Similar papers in this journal
5
Nature
○ 645 papers in training set
Top 3%
4.4%
Similar papers in this journal
6
Nature Chemical Biology
○ 119 papers in training set
Top 0.6%
4.1%
7
Science Advances
● 1243 papers in training set
Top 9%
3.6%
50% of probability mass above
8
Cancer Discovery
● 66 papers in training set
Top 0.7%
3.3%
9
Journal of Experimental Medicine
● 119 papers in training set
Top 1.0%
2.8%
10
Journal of Clinical Investigation
● 179 papers in training set
Top 2%
2.7%
11
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 21%
2.4%
12
Redox Biology
○ 70 papers in training set
Top 0.5%
2.4%
13
Cell Reports
○ 1498 papers in training set
Top 17%
2.0%
14
Cell Death & Disease
147 papers in training set
Top 2%
1.8%
15
Blood
● 74 papers in training set
Top 0.8%
1.8%
16
Molecular Cell
○ 350 papers in training set
Top 3%
1.7%
17
Cell Chemical Biology
○ 94 papers in training set
Top 1%
1.1%
18
The EMBO Journal
○ 309 papers in training set
Top 4%
1.1%
19
Cell Research
○ 51 papers in training set
Top 0.8%
1.1%
20
Nature Cancer
○ 39 papers in training set
Top 1%
1.1%
21
Cell Stem Cell
○ 62 papers in training set
Top 1%
1.1%
22
Science
● 477 papers in training set
Top 7%
1.1%
23
Nature Metabolism
○ 69 papers in training set
Top 1%
1.1%
24
Communications Biology
○ 993 papers in training set
Top 20%
1.1%
25
Cell
○ 431 papers in training set
Top 9%
1.1%
26
EMBO Molecular Medicine
○ 95 papers in training set
Top 2%
1.0%
27
Advanced Science
○ 286 papers in training set
Top 8%
1.0%
28
Cancer Research
● 130 papers in training set
Top 3%
1.0%
29
Cell Metabolism
○ 57 papers in training set
Top 1%
0.9%
30
EMBO Reports
○ 263 papers in training set
Top 6%
0.9%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.